Details for Patent: 8,653,092
Which drugs does patent 8,653,092 protect, and when does it expire?
Patent 8,653,092 protects JOENJA and is included in one NDA.
This patent has forty-nine patent family members in forty-three countries.
Summary for Patent: 8,653,092
| Title: | Tetrahydro-pyrido-pyrimidine derivatives |
| Abstract: | The invention relates to substituted tetrahydro-pyrido-pyrimidine derivatives of the formula (I), wherein Y, R1, R2 and m are as defined in the description. Such compounds are suitable for the treatment of a disorder or disease which is mediated by the activity of the PI3K enzymes. |
| Inventor(s): | Nigel Graham Cooke, Paulo FERNANDES GOMES DOS SANTOS, Nadege GRAVELEAU, Christina HEBACH, Klemens Högenauer, Gregory Hollingworth, Alexander Baxter Smith, Nicolas Soldermann, Frank Stowasser, Ross Strang, Nicola TUFILLI, Anette Von Matt, Romain Wolf, Frédéric Zecri |
| Assignee: | Novartis AG |
| Application Number: | US13/175,050 |
|
Patent Claim Types: see list of patent claims | Composition; Compound; |
Drugs Protected by US Patent 8,653,092
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pharming | JOENJA | leniolisib phosphate | TABLET;ORAL | 217759-001 | Mar 24, 2023 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | Y | Y | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 8,653,092
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| European Patent Office | 2590974 | ⤷ Start Trial | 301386 | Netherlands | ⤷ Start Trial |
| European Patent Office | 2590974 | ⤷ Start Trial | CA 2026 00029 | Denmark | ⤷ Start Trial |
| European Patent Office | 2590974 | ⤷ Start Trial | C20265013 | Finland | ⤷ Start Trial |
| European Patent Office | 2590974 | ⤷ Start Trial | 2026C/725 | Belgium | ⤷ Start Trial |
| European Patent Office | 2590974 | ⤷ Start Trial | PA2026527 | Lithuania | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
